InsiderTrades

Form 4 for TBPH Theravance Biopharma, Inc.

Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-13 · accession 0001415889-25-017585 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
I 2025-06-17 2025-06-13 TBPH Winningham Rick E CEO, Dir G - Gift $0.00 +9,600 13.5K +246% $0
2025-06-17 2025-06-13 TBPH Winningham Rick E CEO, Dir G - Gift $0.00 -9,600 1.75M -0.5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-06-13 G A 9,600 $0.00 13,500 I As Custodian — — (F1) Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. (F2) The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.
2 Common Ordinary Shares 2025-06-13 G D 9,600 $0.00 1,753,180 D — — (F1) Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.